Sensitive induction of apoptosis in breast cancer cells by a novel 1,25- dihydroxyvitamin D3 analogue shows relation to promoter selectivity

Journal of Cellular Biochemistry

Volumn 66, Issue 4, 1997, Pages 552-562

  Danielsson, Carina ^a   Mathiasen, Ida S ^b   James, Sharon Y ^c   Nayeri, Sepideh ^a   Bretting, Claus ^b   Hansen, Christina Mørk ^b   Colston, Kay W ^c   Carlberg, Carsten ^a,d  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b LEO Pharmaceutical Products   (Denmark)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Apoptosis; Breast cancer; Control of proliferation; Promoter selectivity; Regulation of transcription; Tumor regression; Vitamin D3 analogues; Vitamin D3 receptor

Indexed keywords

CALCITRIOL; COLECALCIFEROL; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; DIAGNOSIS; DRUG POTENCY; FEMALE; GROWTH INHIBITION; GROWTH REGULATION; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CALCITRIOL; CALCIUM; CELL DIVISION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, INBRED LEW; RATS, INBRED STRAINS; RATS, WISTAR; RECEPTORS, CALCITRIOL; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0030843041     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19970915)66:4<552::AID-JCB14>3.0.CO;2-D     Document Type: Article

References (38)

1. 3: Direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 15:5789-5799.
2. Bouillon R, Okamura WH, Norman AW (1995): Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16:200-257.
3. Calverley MJ, Grue-Sorensen G, Bretting C, Binderup L (1995): Chemistry and biology of highly active 22-oxy analogs of 20-epi calcitrol with very low binding affinity to the vitamin D receptor. In Norman AW, Bouillon R, Thomasset M (eds): "Proceedings of the Ninth Workshop on Vitamin D." Berlin: de Gruyter, pp 85-86.
4. Candeliere GA, Jurutka PW, Haussler MR, St-Arnaud R (1996): A composite element binding the vitamin D receptor, retinoid X receptor α, and a member of the CTF/NF-1 family of transcription factors mediates the vitamin responsiveness of the c-fos promoter. Mol Cell Biol 16:584-592.
5. 3: Interplay with retinoid and thyroid hormone signalling. Eur J Biochem 231:517-527.
6. 3 analogues. Dermatology 192:195-197.
7. 3 receptor in the context of the nuclear receptor superfamily: the central role of retinoid X receptor. Endocrine 4:91-105.
8. Carlberg C, Bendik I, Wyss A, Meier E, Sturzenbecker LJ, Grippo JF, Hunziker W (1993): Two nuclear signalling pathways for vitamin D. Nature 361:657-660.
9. 3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers. Mol. Cell. Biol. 14:3329-3338.
10. Colston KW, Berger U, Coombes RC (1989): Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1:188-191.
11. Colston KW, Mackay AG, James SY, Binderup L, Chander S, Coombes PC (1992): EB1089: A new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem Pharmacol 44:2273-2280.
12. 3 analogues: A novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res 55:2822-2830.
13. 3 analogue (KH1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. Cancer Res 56:3570-3576.
14. 3 metabolites. Cancer Res 43:4443-4447.
15. James SY, Mackay AG, Binderup L, Colston KW (1994): Effects of a new synthetic vitamin D analogue, EB1089, on the estrogen-responsive growth of human breast cancer cells. J Endocrinol 141:555-563.
16. James SY, Mackay AG, Colston KW (1995): Vitamin D derivatives in combination with 9-cis-retinoic acid promote active cell death in breast cancer cells. J Mol Endocrinol 14:391-394.
17. Jones G, Calverley MJ (1993): A dialogue on analogues. Trends Endocrinol Metab 4:297-303.
18. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10:142-153.
19. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM (1995): The nuclear receptor superfamily: the second decade. Cell 83:835-839.
20. Masuda S, Strugnell S, Calverley MJ, Makin HLJ, Kremer R, Jones G (1994): In vitro metabolism of the antipsoriatic vitamin D analog calcipotriol, in two cultured human keratinocyte models. J Biol Chem 269:4794-4803.
21. Mathiasen IS, Colston KW, Binderup L (1993): EB1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells. J Steroid Biochem Mol Biol 46:365-371.
22. 3 in human breast cancer MCF-7 cells is related to promoter selectivity. Int J Cancer 67: 739-742.
23. Mørk Hansen C, Mathiasen IS, Binderup L (1996b): The anti-proliferative and differentiation-inducing effects of vitamin D analogues are not determined by the binding affinity for the vitamin D receptor alone. J Invest Dermatol 106:S44-S48.
24. 3 analogues is not related to the AP-1 pathway, but related to promoter selectivity. Oncogene 11:1853-1858.
25. 3 correlates well with gene activation. J Cell Biochem 62:325-333.
26. 3 receptors: structure and function in transcription. Annu Rev Nutr 11:189-216.
27. Pols HAP, Birkenhäger JC, van Leeuven JPTM (1994): Vitamin D analogues: From molecule to clinical application. Clin Endocrinol 40:285-291.
28. Pothier F, Quellet M, Julien J-P, Guérin SL (1992): An improved CAT assay for promoter analysis in either transgenic mice or tissue culture cells. DNA Cell Biol 11:83-90.
29. Schräder M, Müller KM, Carlberg C (1994): Specificity and flexibility of vitamin D signalling: Modulation of the activation of natural vitamin D response elements by thyroid hormone. J Biol Chem 269:5501-5504.
30. 3 response elements formed by inverted palindromes: Polarity-directed ligand sensitivity of VDR-RXR heterodimer-mediated transactivation. Mol Cell Biol 15:1154-1161.
31. 3 response element identified in the mouse c-fos promoter. Biochem Biophys Res Commun 230:646-651.
32. Sheikh MS, Rochefort H, Garcia M (1995): Overexpression of p21WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene 11:1899-1905.
33. Vieth R (1990): The mechanisms of vitamin D toxicity. Bone Miner 11:267-272.
34. Walters MR (1992): Newly identified actions of the vitamin D endocrine system. Endocr Rev 13:719-764.
35. Welsh J (1994): Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens. Biochem Cell Biol 72:537-545.
36. Welsh J, Simboli-Campbell M, Narvaez CJ, Tenniswood M (1995): Role of apoptosis in the growth inhibitory effects of vitamin D in MCF-7 cells. Adv Exp Med Biol 375: 45-52.
37. Wilkinson JR, Williams JC, Singh D, Gross PE, Easton D, Coombes RC (1986): Response of nitrosomethylurea-induced rat mammary tumor to endocrine therapy and comparison with clinical response. Cancer Res 46:4862-4865.
38. Zhang Q, Wrana JL, Sodek J (1992): Characterization of the promoter region of the porcine opn (osteopontin, secreted phosphoprotein 1) gene. Eur J Biochem 207:649-659.